LINQ II Insertable Cardiac Monitor vs Vivid T9/Vivid T8
AI Verdict
Choose LINQ II Insertable Cardiac Monitor if…
Choose the LINQ II Insertable Cardiac Monitor if your patient requires long-term, continuous heart rhythm monitoring for the diagnosis of infrequent or unexplained arrhythmias that may not be captured by shorter-term external devices. Its AI-powered accuracy and up to 4.5 years of monitoring provide a comprehensive solution for extended diagnostic periods, including remote management capabilities.
View LINQ II Insertable Cardiac Monitor →Choose Vivid T9/Vivid T8 if…
Choose the Vivid T9/T8 Cardiovascular Ultrasound Systems if your clinical practice demands real-time, high-quality cardiovascular imaging with integrated AI-powered tools to enhance diagnostic accuracy and workflow efficiency during patient exams. These systems are ideal for immediate assessment of cardiac structure and function, offering shared services capabilities for broader imaging needs.
View Vivid T9/Vivid T8 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | LINQ II Insertable Cardiac Monitor | Vivid T9/Vivid T8 |
|---|---|---|
| Deployment | Subcutaneous implant with remote monitoring via mobile app or home communicator. | Unknown |
| FDA Status | Cleared AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
LINQ II Insertable Cardiac MonitorTool A, the LINQ II, offers superior usability by focusing on both patient and clinician experience. Its MyCareLink Heartu2122 mobile app and remote programming capabilities significantly reduce the need for in-office visits and streamline data transmission for patients, while the Reveal LINQ Mobile Manager app simplifies device activation and programming for clinicians.
Clinical Value
LINQ II Insertable Cardiac MonitorThe LINQ II demonstrates strong clinical value through its AccuRhythmu2122 AI algorithms, which provide enhanced accuracy in diagnosing arrhythmias and significantly reduce false alerts, saving valuable clinic time. Clinical studies, such as DEFINE AFib, validate its effectiveness in detecting AF episodes and risk-stratifying patients, with a clear impact on patient management.
Pricing & Value
Vivid T9/Vivid T8Tool B, the Vivid T9/T8, offers greater pricing transparency with a publicly stated starting price for the Vivid T8 around $22,800 and includes a 3-year service coverage, providing a clearer upfront value proposition. While Tool A's enterprise pricing is not disclosed, Tool B's transparent pricing and included service package give it an edge in this dimension.
Enterprise Readiness
TieBoth tools exhibit strong enterprise readiness tailored to their respective domains. Tool A offers hybrid deployment, HIPAA compliance, FDA clearance, and an established CareLink network for remote patient management, supporting over a million patients. Tool B provides on-premise hardware, supports HIPAA compliance, is FDA cleared, and features DICOM connectivity and integration with comprehensive imaging and reporting ecosystems like EchoPACu2122 and ViewPoint EchoPilotu2122.
Innovation
LINQ II Insertable Cardiac MonitorTool A, the LINQ II, showcases significant innovation with its AccuRhythmu2122 AI algorithms that dramatically reduce false alerts in an implantable cardiac monitor, improving diagnostic accuracy and clinician efficiency. Its remote programming capability for an implanted device also represents a notable advancement in patient care and device management.
Support & Docs
TieBoth companies provide comprehensive support and documentation. Medtronic (Tool A) offers 24-hour technical support, educational resources, and dedicated patient support services. GE HealthCare (Tool B) provides extensive service and user manuals, application support, and advanced remote service capabilities via InSiteu2122 ExC.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | LINQ II Insertable Cardiac Monitor | Vivid T9/Vivid T8 |
|---|---|---|
| Product Type | Insertable Cardiac Monitor | Cardiovascular Ultrasound Systems |
| Company | Medtronic | GE HealthCare |
| Key AI-Powered Features | AccuRhythmu2122 AI algorithms for enhanced accuracy, Remote programming capability, Innovative PVC detection algorithm | AI-based Cardiac Auto Doppler for automated measurements, AutoEF (Automated Ejection Fraction), Automated Function Imaging (AFI) |
| Specialties | Cardiology | Cardiology, Critical Care, Radiology |
| Mobile App Support | both (MyCareLink Heartu2122 mobile app) | Not specified |
| Customer Count / Scale | More than 1 million patients have received a Medtronic ICM worldwide | Not specified |
Videos
Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and Vivid T9/Vivid T8.